About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 383 record(s)
Req # A-2023-000448
Adverse Drug Reactions (ADRs). Report numbers: E2B_05763376, E2B_06311891, E2B_06321734, E2B_06269245, E2B_06272971, E2B_06321741, 001037727.Organization: Health Canada
September 2023
Req # A-2023-000450
Adverse Drug Reactions (ADRs). Report numbers: 001038279, E2B_06331263.Organization: Health Canada
September 2023
Req # A-2023-000451
Adverse Drug Reaction (ADR) for DEXILANT. Report number: E2B_06317830. ADRs for ENTYVIO. Report numbers: 001037118, E2B_06297130, 001035880. ADRs for ONDANSETRON. Report numbers: E2B_06293443, E2B_06298982, E2B_06333994, E2B_06304558, E2B_06322121,…Organization: Health Canada
September 2023
Req # A-2023-000468
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-103496-815, Investing in Canada Plan.Organization: Health Canada
September 2023
Req # A-2023-000469
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-103754-435.Organization: Health Canada
September 2023
Req # A-2023-000477
Adverse Drug Reactions (ADRs). Report numbers: E2B_06307970, 001038412, E2B_06307631, 001037612, 001038278, 001038993, E2B_06274285, 001040196, E2B_06332889, E2B_06286966.Organization: Health Canada
September 2023
Req # A-2023-000478
Adverse Drug Reactions (ADRs). Report numbers: E2B_06333161, E2B_06283221, E2B_06288346, 001035117, E2B_06310891, E2B_06310879, E2B_06297285, 001037269, E2B_06269245, 001036556.Organization: Health Canada
September 2023
Req # A-2023-000484
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-102152-249.Organization: Health Canada
September 2023
Req # A-2023-000529
Adverse Drug Reaction (ADR). Report number: E2B_02891245.Organization: Health Canada
September 2023
Req # A-2023-000546
Adverse Drug Reaction (ADR) for PMS-AZITHROMYCIN. Report number: E2B_06272934.Organization: Health Canada
September 2023